Insilico Medicine to present its latest results in generative chemistry AI Applications Summit

(InSilico Medicine, Inc.) Alex Zhavoronkov, Founder and CEO of Insilico Medicine presents 'The Power of GANs and RL in pharma R&D: from Experimentally-Validated End-to-End Drug Discovery Pipelines to Generation of Synthetic Patients' at The AI Applications in Biopharma Summit 2018 in Boston.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2SeNugy